GAS5 and androgen insensitivity syndrome: To explore the correlation between lnc‐GAS5 and the prognosis of patients with AIS, patients with AIS were followed up for 36 months, which revealed that elevated lnc‐GAS5 was correlated with shorter RFS (p = 0.036), and RFS was significantly shorter in patients with lnc‐GAS5 levels in Q4 than in patients with lnc‐GAS5 levels in Q1 (p = 0.010; Figure 4).